Stay updated with breaking news from Philip stellarex. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Philips announces positive three-year clinical research results from its Tack Optimized Balloon Angioplasty (TOBA) II below-the-knee (BTK) clinical trial | Comunicados | Edición USA efe.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from efe.com Daily Mail and Mail on Sunday newspapers.
For below-the-knee arterial dissection repair following balloon angioplasty, innovative medical technology shows sustained treatment effect and positive impact on quality of life for patients with critical limb ischemia (CLI) ....
Journal of the American College of Cardiology) Stroke survivors trying to regain arm function in rehabilitation found incremental improvement with vagus nerve stimulation in the VNS-REHAB trial. ( The Lancet) The American College of Physicians released a guideline on the use of point-of-care ultrasound for patients with acute dyspnea. A theory posits that dual SGLT1 and SGLT2 inhibition could improve cardiovascular outcomes for people with diabetes. ( Circulation) Philips Stellarex paclitaxel drug-coated balloon did not increase deaths at 5 years over percutaneous transluminal angioplasty in a 600-patient meta-analysis supporting its safety. Clotting drug tranexamic acid did not raise complication rates for high-risk patients undergoing orthopedic surgeries. ( ....
Operator Welcome to the Royal Philips Fourth Quarter and Full Year 2020 Results Conference Call on Monday, January 25, 2021. During the call hosted by Mr. Frans van Houten, CEO; and Mr. Abhijit Bhattacharya, all participants will be in a listen-only mode. [Operator Instructions] I will now hand the conference over to Mr. Leandro Mazzoni, Head of Investor Relations. Please go ahead, sir. Leandro Mazzoni Head of Investor Relations Good morning, ladies and gentlemen. Welcome to Philips fourth quarter and full year 2020 results conference call. I m here with our CEO, Frans van Houten; and our CFO, Abhijit Bhattacharya. On today s call, Frans will take you through our strategic and financial highlights for the period. Abhijit will then provide more detail on the financial performance. And after that, we will take your questions. ....